Hemostats hold three major functions, especially in the emergency wound care. The hemostats were initially designed to compress the smaller blood vessels for the control of hemorrhage. Another major use of hemostats is to grasp and give optimal security superficial fascia in debriding and undermining wounds. Ultimately, hemostats turned out to be a brilliant tool for exploring, exposing, as well as visualizing the deep areas of any wound. There are two main types of hemostats that are commonly used in wound care. For the general use, the standard or the regular hemostat is advised. For the smaller wounds, finer work is mostly recommended which is used in combination with 5-inch curved mosquito hemostat along with fine serrated jaws.
Hemostatic agents market was estimated to be over US$ 3 Bn in 2018. It is anticipated to grow at a CAGR of 6.1% from 2019 to 2030.
Surge in the number of surgical procedures conducted globally is expected to contribute towards the growth of the hemostatic agents market. The growth of the global market is further fueled by factors such as rising adoption of hemostats to restrain bleeding, rise in geriatric population requiring surgical procedures for various ailments, growing research and development activities worldwide. Owing to the growing demand for hemostatic agents that are quicker and cheaper, there is a remarkable opportunity for the key players in the hemostatic agents market to fill in this gap. Allergic reactions to human plasma or animal derived component in the hemostatic agents is anticipated to hamper the growth of this market.
Download PDF to Know the Impact of COVID-19 on “Hemostatic Agents Market” at: https://www.marketindustryreports.com/pdf/56
Major Key Players of the Hemostatic Agents Market are:
Baxter, Ethicon US, C. R. Bard, B. Braun Melsungen AG, Pfizer, Z-Medica, CryoLife, Integra LifeSciences, Advanced Medical Solutions Group plc. GELITA AG.
There is a perpetual rise in the number of surgical procedures across the globe. Minimally invasive procedures are further driving the surgical volumes up. There has been a significant rise in health awareness among population and ample measures have introduced appropriate and effective treatments for diseases. Steady rise in geriatric population that requires medical attention and surgery to treat several aliments is fueling the demand for hemostatic agents, thus boosting the growth of the global hemostatic agents market. Hemostatic agents enable the surgeons to undertake technically challenging and complex surgical procedures, owing to the hemostat’s ability to curb bleeding in a quicker and effective manner. Moreover, the hemostatic agents can be used across diverse medical applications, hence the surge in surgical procedures is expected to propel the growth of this market.
The Hemostatic Agents Market is segmented on the basis of Product Type, Specialty, Size of Hospitals and region.
Major Product Type of Hemostatic Agents Market covered are:
- Active, Passive
- Combination
Major Specialty of Hemostatic Agents Market covered are:
- Cardiology
- Cath Lab
- Trauma
- General Surgery
- Obgyn
- Transplant
- Oncology
- Neurology
- Orthopedic
- Plastic Surgery
- Dental
Major Size of Hospitals of Hemostatic Agents Market covered are:
Large Hospitals
- 500 + Beds
Medium Hospitals
- 250-499 Beds
- Small Hospitals (Less than 250 Beds)
There is an effort by the key players in this market to launch hemostatic agents that are more efficacious and faster in order to meet the growing needs by doctors to handle disruptive bleeds. Value added features are being offered by multiple hemostatic agents, to offer pertinent medical aid and treatment options. The advent of advanced hemostatic agents is resulting in better patient outcomes thus propelling the growth of the global hemostatic agents market. These aspects help the medical fraternity to dispense fast-acting and safe treatments to their patients. Players in the Hemostatic Agents Market are focusing on developing and launching products with value added features that provide quicker healing, more safety and efficacy thereby providing an advanced product that is an enhanced version of the existing products in the market.
Research objectives:-
– To study and analyze the global Hemostatic Agents consumption (value & volume) by key regions/countries, product type and application, history data.
– To understand the structure of the Hemostatic Agents market by identifying its various sub-segments.
– Focuses on the key global Hemostatic Agents manufacturers, to define, describe and analyze the sales volume, value, market share, market competitive landscape, SWOT analysis, and development plans in the next few years.
– To analyze the Hemostatic Agents with respect to individual growth trends, future prospects, and their contribution to the total market.
– To share detailed information about the key factors influencing the growth of the market (growth potential, opportunities, drivers, industry-specific challenges and risks).
Have any query? Inquiry about report at: https://www.marketindustryreports.com/inquiry/56
Table of Contents
- INTRODUCTION
- Market Definition
- Market Ecosystem
- Currency Used for the Study
- RESEARCH METHODOLOGY
- Research Framework
- Data Collection Technique
- Data Sources
- Market Estimation Methodology
- Data Validation and Triangulation
- ABSTRACT OF THE STUDY
- MARKET DYNAMICS ASSESMENT
- Overview
- Drivers
- Barriers/Challenges
- Opportunities
- UNIQUE SELLING PROPOSITIONS (USPs)
- Regulatory/Reimbursement Scenario (Key Countries)
- Comparative Assement of Key Products
- Pricing Analysis by Type
- Key Distributors (Snapshot)
- Global Market – Analysis & Forecast, By Product Type
- Active
- Passive
- Combination
- Global Market – Analysis & Forecast, By Specialty
- Cardiology
- Cath Lab
- Trauma
- General Surgery
- Obgyn
- Transplant
- Oncology
- Neurology
- Orthopedic
- Plastic Surgery
- Dental
- Others
- Global Market – Analysis & Forecast, By Size of Hospitals
- Large Hospitals (500 + Beds)
- Medium Hospitals (250-499 Beds)
- Small Hospitals (Less than 250 Beds)
- Global Market – Analysis & Forecast, By Region
- North America Market
- Europe Market
- Asia Pacific Market
- Rest of the World (ROW) Market
- COMPETETIVE LANDSCAPE
- Market Share Analysis (2018)
- Key Strategies Assessment
- New Product Launches
- Merger & Acquisitions
- Agreements, Collaborations, & Partnerships
- Expansions
- Other Strategies
- COMPANY PROFILES (Business Overview, Products/Services Offered, Financial Performance, R&D Intensity, Marketing & Sales Intensity, Recent Developments, Analyst Corner)*
- Baxter
- Ethicon US, LLC
- C. R. Bard, Inc.
- B. Braun Melsungen AG
- Pfizer Inc.
- Z-Medica, LLC
- CryoLife, Inc.
- Integra LifeSciences
- Advanced Medical Solutions Group plc.
- GELITA AG.
*Financial details might not be captured in case of privately-held companies or for companies that do not report this information in public domain
Buy Exclusive Report @ https://www.marketindustryreports.com/checkout/56
About Us
Market Industry Reports is a global leader in market measurement and advisory services. It is 100% subsidiary of Maniks Systems Pvt Ltd. The firm has always been at the forefront of innovation to address the worldwide industry trends and opportunities.
We offer our clients a unique depth of market intelligence in an actionable format to move their business forward. Our analysis incorporates the consumer study in more than 100 countries that provide a tactical approach to drive the sustained growth for the business. We continue to pioneer state-of threat approach in research & analysis that makes complex world simpler to stay ahead of the curve. By nurturing the perception of genius and optimized market intelligence we bring proficient contingency to our clients in the evolving world of technologies, megatrends and industry convergence. We empower and inspire Vanguards to fuel and shape their business to build and grow world-class consumer products.
Contact Us-
Email: sales@marketindustryreports.com
Phone: + 91 8956767535
Website: https://www.marketindustryreports.com